keytruda - pembrolizumab injection, powder, lyophilized, for solution
(Pembrolizumab)Merck Sharp & Dohme Llc
Usage: KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.